ライフサイエンスコーパス: molecular marker

1 rmones and could be clarified using NR1 as a molecular marker.

2 cytochrome oxidase subunit I gene (COXI) as molecular marker.

3 h for early diagnosis of DR and VEGFR-2 as a molecular marker.

4 the performance of DeltaNP63alpha, a common molecular marker.

5 clinical stratification of patients based on molecular markers.

6 ult of reclassification of common cancers by molecular markers.

7 rphology, but did not drive expression of MG molecular markers.

8 selection-driven outliers on next-generation molecular markers.

9 nsitization, but also the increases in these molecular markers.

10 nd the intratumoral distribution of specific molecular markers.

11 ell types of diverse origins, functions, and molecular markers.

12 mation of the growing number of clinical and molecular markers.

13 other option is to predict heading date from molecular markers.

14 guidelines and to assess the accuracy of new molecular markers.

15 ase, as assessed by various pathological and molecular markers.

16 accounted for by using specific fluorescent molecular markers.

17 ne each mode and identify its phenotypic and molecular markers.

18 ged, such as thyroid stimulating hormone and molecular markers.

19 as subsequently constructed by using bins as molecular markers.

20 ased solely on histology, with an absence of molecular markers.

21 d gene expression, respectively, of relevant molecular markers.

22 f their projection target and discover their molecular markers.

23 eural pathways has suffered due to a lack of molecular markers.

24 he clinical and therapeutic utility of these molecular markers.

25 espective applications as pharmaceuticals or molecular markers.

26 ly classified using location, morphology and molecular markers.

27 s system via lineage-specific GAL4 lines and molecular markers.

28 ive analyses of progression-free survival by molecular markers (1p/19q co-deletion, MGMT promoter met

29 The linkage map was comprised of 972 molecular markers (538 Bin, 258 AFLPs, 175 SSRs, and an

30 Preoperative risk stratification using molecular markers also may be used to better define the

31 ation, giving a new map with a total of 2041 molecular markers and an average marker density which in

32 richment analyses to discover group-specific molecular markers and did immunohistochemical analyses o

33 Three delimitation approaches (morphology, molecular markers and geography) were applied providing

34 Adipogenesis was monitored by molecular markers and histology.

35 Studies now aim to identify molecular markers and imaging techniques that can detect

36 Using a repertoire of molecular markers and inhibitors, we find that the Lh-Lh

37 bolomics methods have already identified new molecular markers and metabolomic signatures of cardiova

38 A diagnostic algorithm consisting of two molecular markers and one consensus histologic feature w

39 candidate regions were created using linked molecular markers and tested for memory retention.

40 that are indistinguishable using traditional molecular markers and that draw substantial conservation

41 This study investigated novel molecular markers and their age-related changes in the r

42 y of ovarian cancer, identify tumor-specific molecular markers, and develop novel treatment modalitie

43 histopathological features, cytogenetic and molecular markers, and reversal of cytopenias) were not

44 leotide Polymorphisms (SNPs) are widely used molecular markers, and their use has increased massively

45 Molecular markers are not used in diagnosis or determina

46 up to three generations before conventional molecular markers are observable.

47 on sampling, comparative morphology, and new molecular markers are required for a better understandin

48 generate image contrast, thus excluding many molecular markers as potential targets.

49 trend in the development and application of molecular marker assays for gene mapping and discovery i

50 genic traits in perennial species can inform molecular marker-assisted breeding.

51 This information may be used in molecular marker-assisted selection of cattle breeding i

52 lex DNA devices able to sense and respond to molecular markers associated with abnormal metabolism.

53 ral vascularization and proper expression of molecular markers associated with BBB formation.

54 e transcriptome sequencing to identify novel molecular markers associated with BP response to TD.

55 mice exhibited an increase in expression of molecular markers associated with dyskinesias.

56 enous laminin-511 restores morphological and molecular markers associated with hair matrix formation,

57 viruses infecting humans to rapidly acquire molecular markers associated with mammalian adaptation a

58 We evaluated the impact of molecular markers at baseline and during follow-up in 38

59 encing metastatic tumour genomes to identify molecular markers at this lethal stage of disease.

60 (HmtDNA) as a new, potentially more reliable molecular marker, because it can be unambiguously source

61 uate (14)C records for two complementary PyC molecular markers, benzene polycarboxylic acids (BPCAs)

62 RS Motor subscale; R = 0.903; P < .001), the molecular marker (BOP; R = 0.908; P < .001), and regiona

63 gy of these conditions by defining objective molecular markers but also aid in margin assessment to i

64 inin resistance can be tracked using the K13 molecular marker, but no marker exists for piperaquine r

65 y DA expressed either the arterial or venous molecular marker, but rarely both.

66 ssociated changes in cardiac performance and molecular markers, but do not have findings consistent w

67 ith the reversal of corticosteroid-resistant molecular markers by RNO.

68 (1100-1200 CE), successfully detecting three molecular markers, caffeine, theobromine, and theophylli

69 These findings indicate that a molecular marker can be used to accelerate introduction

70 Molecular markers can allow subtypes of tumors of the sa

71 Analysis of cymbidiums genetic background by molecular markers can be of great value in assisting par

72 This suggests that molecular markers can be used to roughly estimate the ma

73 els were associated with enhanced senescence molecular markers, chlorophyll degradation, and earlier

74 The molecular markers closely linked to the QTL reported her

75 or immunostaining, demonstrated that the 12 molecular markers collectively define 10 different sSC n

76 The approach-informed by regional molecular markers, concurrent Alzheimer's pathology anal

77 Double labeling with other molecular markers confirmed that the labeled SGNs were n

78 ished analogies strongly suggest that common molecular markers contribute to the calorimetric profile

79 ided additional information, suggesting that molecular markers could be used in combination with hemo

80 The integration of both clinical and molecular markers could provide a basis for individualiz

81 These ECs, expressing the venous molecular markers Coup-TFII and EphB4, cohabited the ear

82 ely based on morphological evidence, as most molecular markers currently employed are generally inade

83 peats were identified, which will facilitate molecular marker development.

84 phological structures and cell type-specific molecular markers differentially expressed along the ant

85 Molecular markers downstream of gemcitabine treatment in

86 to patients most likely to be enrolled onto molecular-marker-driven trials and that the tests are bi

87 e transcription and is associated with other molecular markers (e.g. gene expression) and biomarkers

88 he early DA with ECs expressing the arterial molecular markers ephrin B2, Notch and connexin 40.

89 Using K13 mutations as molecular markers, epidemiological studies are now track

90 Anatomy, molecular marker expression, and electrophysiological an

91 Retrograde labeling, molecular marker expression, electrophysiological analys

92 A common molecular marker for all osteogenic mesenchymal progenit

93 asma membrane with CAV1 and Cavin-1, another molecular marker for caveolae in both cell phenotypes.

94 ps to the SfABCC2 gene and provides a useful molecular marker for detecting the SfABCC2mut allele in

95 ur results indicate that TSPO is a promising molecular marker for imaging inflammatory cell activatio

96 -propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to

97 mplicate IRX1 hypomethylation as a potential molecular marker for lung metastasis, and suggest that e

98 o studies, the expression of synaptopodin, a molecular marker for podocyte integrity, and the slit di

99 via levels of phosphorylation (P-S6k), is a molecular marker for sedation and overall neuronal activ

100 rtial FLAG epitope may itself be useful as a molecular marker for the rapid screening of citrus plant

101 f UGT2B15 and UGT2B17 as drug targets and/or molecular markers for ADTh responsiveness and maintenanc

102 or set of traits is essential for developing molecular markers for alfalfa breeding.

103 rpretation of in vitro sensitivity tests and molecular markers for artemisinin resistance and for con

104 obtain urinary cytology or other urine-based molecular markers for bladder cancer detection in the in

105 nd MYH7, respectively, which are established molecular markers for cardiac remodeling.

106 nt to which visible indicators correspond to molecular markers for cardiovascular stress is unknown f

107 nity for machine learning models to identify molecular markers for disease diagnosis and progression.

108 need for developing comprehensive panels of molecular markers for early disease detection and precis

109 dopsis HY5, MAF3, RVE1 and RD22 as potential molecular markers for endodormancy in crown buds of leaf

110 atient survival and established clinical and molecular markers for favorable tumor biology, including

111 uality, including identification of possible molecular markers for flavor characterizing.

112 which should be helpful to select candidate molecular markers for functionally different neurons in

113 Based on quantitative bioimaging and molecular markers for genetic and signaling aberrations,

114 oteins such as parvalbumin and calbindin are molecular markers for interneuron subtypes, and are co-e

115 s in physiological parameters were observed, molecular markers for iron starvation, such as Iron Star

116 s and a variety of spinal systems, providing molecular markers for known and unknown neuron populatio

117 and may eventually lead to identification of molecular markers for liver cancer diagnosis, treatment

118 otide polymorphisms (SNPs) are the benchmark molecular markers for modern genomics.

119 inflammation and lung function and identify molecular markers for neutrophilic asthma.

120 ous, identification of clinically meaningful molecular markers for outcome prediction is challenging.

121 silviculture, only a very limited number of molecular markers for pathogen resistance have been vali

122 rtemisinin-resistant parasites may yield new molecular markers for resistance surveillance, which may

123 response could lead to the identification of molecular markers for response as well as possible clini

124 Existing molecular markers for transformation are few and their c

125 d among clinical specimens with serologic or molecular markers for various unrelated blood-borne viru

126 descent infection by parasites with the same molecular markers from days 8 to 42 (defined as cure).

127 So far, no specific molecular marker has been identified in the remaining 30

128 The lack of a specific molecular marker has left the diagnosis to be largely on

129 T: The identification of cell-type-selective molecular markers has fostered tremendous insight into h

130 The identification of cell-type-selective molecular markers has fostered tremendous insight into h

131 Research on molecular markers has revealed many potential targets fo

132 monosomal karyotype and various genetic and molecular markers have also been shown to have a prognos

133 ades, several novel biological, genetic, and molecular markers have been shown to be useful adjuncts

134 Molecular markers have been used to study parasite trans

135 However, molecular markers have failed to reveal subtle biogeogra

136 ues, transgenic lines and well-characterized molecular markers, have made histological assessment of

137 Due to selection of different molecular markers, however, integrating all the datasets

138 Although the molecular markers identified have been reported to be im

139 n) may represent a prognostic and predictive molecular marker in prostate cancer.

140 ic description of germ cell development with molecular markers in a myriapod, the centipede Strigamia

141 ers that identify the presence of genetic or molecular markers in a patient's cancer to select approp

142 probably use blood-specific or lung-specific molecular markers in combination with other clinical, ph

143 the rapid and reliable detection of multiple molecular markers in complex samples.

144 (TRs), or microsatellites, are often used as molecular markers in genetics, and clinically, variation

145 DNA is one of the most extensively sequenced molecular markers in plant systematics.

146 Defining the potential utility of molecular markers in predicting response or failure of r

147 This approach led to the identification of molecular markers in Solanum lycopersicum L. and Cucurbi

148 analgesic nalbuphine in reducing LID and its molecular markers in the nonhuman primate model.

149 Furthermore, evaluation of molecular markers in the testes of patients with nonobst

150 The similarity between the quantity of molecular markers in the water column and effluent indic

151 In both species the putative molecular markers increased their expression soon after

152 Analysis of genetic and molecular markers indicates that SHBY acts in a pathway

153 urons expressed glutamatergic pyramidal cell molecular markers instead of developing a GABAergic iden

154 al T excess increased the gene expression of molecular markers involved in insulin signaling and thos

155 y, no reliable histopathological criteria or molecular marker is known to distinguish borderline from

156 itor the spread of artemisinin resistance, a molecular marker is urgently needed.

157 Genetic analysis of molecular markers is critical in tracking the emergence

158 ) Walp (cowpea) accessions using informative molecular markers is imperative for their genetic improv

159 The rapidly evolving field of molecular markers is reviewed with the intent of promoti

160 e, which is the reference comparator for the molecular marker 'Kelch 13' and in vitro sensitivity tes

161 he primitive streak express many of the same molecular markers, leading to the suggestion that both l

162 Here we use molecular markers, lineage tracing and clonal analysis t

163 Molecular markers linked to spotted wilt resistance coul

164 Further validation of the identified molecular markers may enable the future stratification o

165 idence of steroid resistance; histologic and molecular markers may predict resistance.

166 liculus and suggest that these extracellular molecular markers may provide a key to distinguishing in

167 Here we apply the BPCA molecular marker method to a set of 10 charcoals produce

168 tern Europe using two independent classes of molecular markers, microsatellites (nuclear) and mitocho

169 Molecular markers might improve risk stratification of c

170 Molecular markers might predict disease progression and

171 aboratory methods, sample collection, use of molecular markers, molecular clocks, timeframe, multiple

172 phA2 resulted in the upregulation of the EMT molecular markers N-cadherin and Snail, as well as the W

173 inity for ephrinB2, a molecule proposed as a molecular marker of "stemness" (present on embryonic, he

174 DeltaFosB, a classic molecular marker of addiction, was also measured in meso

175 nin alpha2 has recently been identified as a molecular marker of aggressive ependymoma, we propose th

176 l (LDL-C) and is the single most informative molecular marker of LDL-C response to statins.

177 ngs identify increased amounts of mtDNA as a molecular marker of MD and have important implications f

178 nin gene-related peptide (CGRP) is a classic molecular marker of peptidergic primary somatosensory ne

179 l-expressing neural glial antigen 2, a known molecular marker of pericytes in multiple organs.

180 at identify pTalpha expression as a faithful molecular marker of T lineage commitment.

181 y, we discover that Wntless (Wls) is a novel molecular marker of the cells in the interior face of th

182 N, emphasizing its utility as a new specific molecular marker of the human SAN and as a potential tar

183 red treatment options, and identification of molecular markers of aggressiveness could provide valuab

184 ge predicts survival [1] and associates with molecular markers of aging such as telomere length [2].

185 Our in vitro approach identified novel molecular markers of AngII activity, and the animal stud

186 anscriptome-wide sequencing data to identify molecular markers of antihypertensive drug response.

187 vo, and represents a novel way for unveiling molecular markers of antimalarial drug resistance.

188 were associated with changes in cellular and molecular markers of apoptosis.

189 , multiantigen sequence types (NG-MAST), and molecular markers of azithromycin resistance.

190 e multiantigen sequence types (NG-MAST), and molecular markers of azithromycin resistance.

191 for simultaneous measurement of cellular and molecular markers of cancer.

192 n of PLN protein and increases expression of molecular markers of cardiac hypertrophy in iPSC-CMs.

193 cal circadian genes of E. pulchra to provide molecular markers of circadian timing and also reagents

194 In addition, the discovery of molecular markers of cyst type promises to revolutionize

195 Using microRNA (miRNA) as molecular markers of diseases requires a method for accu

196 ence of parasitaemia and anaemia, to monitor molecular markers of drug resistance, and to measure ins

197 required for high-throughput surveillance of molecular markers of drug resistance.

198 To identify molecular markers of drug response, cell line drug sensi

199 tion on drug sensitivity in cancer cells and molecular markers of drug response.

200 We thereby reproduce molecular markers of each of the second wave cell types

201 gical evidence of insulin-producing cells or molecular markers of endocrine tissue in BM biopsy sampl

202 Molecular markers of epithelial plasticity and fibrosis

203 on for screening the key functional genes or molecular markers of estrus expression in gilts.

204 tochemical studies (Masson trichrome stain), molecular markers of fibrosis (collagen and transforming

205 ssociated with the enhanced co-expression of molecular markers of HR cell death genes and genes for p

206 behavior, glucose homeostasis, endocrine and molecular markers of insulin resistance, and organ weigh

207 Molecular markers of insulin signaling and cardiac hyper

208 testing, questionnaires, and physical data (Molecular Markers of Melanoma Study data set) including

209 We measured 2-HG levels and molecular markers of MRD (WT1 and NPM1) in serial sample

210 Metabolic and molecular markers of muscle metabolism were measured in

211 Therefore, it is essential to identify the molecular markers of NAI resistance among specific NA su

212 Molecular markers of parasite polymorphisms were used to

213 Molecular markers of prion disease include accumulation

214 ovascular structure and function, as well as molecular markers of profibrosis.

215 d to identify stress responsive genes as new molecular markers of quality that can be widely applied

216 licated P. falciparum malaria in relation to molecular markers of resistance.

217 propose that these bacterial proteins mimic molecular markers of self-surfaces, providing a compelli

218 -associated morphology and reduced levels of molecular markers of senescence p16(INK4a) , p53, p21 an

219 reated with morphine and then probed for the molecular markers of slit diaphragm.

220 f the heterogeneous disease characteristics, molecular markers of specific disease phenotypes and mor

221 In this study, we analyzed various molecular markers of T and B cell numbers in neonatal dr

222 crobiologists utilize ribosomal RNA genes as molecular markers of taxonomy in surveys of microbial co

223 ivity of age-related diseases and highlights molecular markers of the aging process that might drive

224 GLO1 inhibitor (pBBG), but not FLX, induced molecular markers of the antidepressant response includi

225 PA and entinostat (MS-275) on behavioral and molecular markers of the effects of haloperidol (HAL) in

226 Using in vivo phage display, we searched for molecular markers of the neurovascular unit, including e

227 ular cells express, natively and in culture, molecular markers of the vascular hematopoietic niche.

228 fear expression versus inhibition; however, molecular markers of these populations remain unknown.

229 ess is independent of known histological and molecular markers of underlying mesenchymal patterns dur

230 nd their oxidation products could be used as molecular markers of VOO freshness to define the VOO aut

231 ng the current or recent effective size from molecular marker or sequence data.

232 However, the best molecular marker or test to use has not yet been identif

233 Most studies focus on molecular markers or analyze data in retrospect.

234 To date there are no distinctive molecular markers or detailed morphologies available for

235 temisia, which are difficult to define using molecular markers or morphology.

236 of endothelial cells (ECs) expressing venous molecular markers, or venous-fated ECs, within the emerg

237 Stable expression of intestine-specific molecular markers parallels loss of markers for the orig

238 Molecular markers potentially can augment the diagnostic

239 133 patients to determine whether candidate molecular markers predicted parasite recrudescence follo

240 on with gas chromatography mass spectrometry molecular markers quantification, underlined the predomi

241 m 57 carbohydrate microarrays and identified molecular markers reflecting a diversity of specific xyl

242 s, mTORC1 signalling, REDD1/2 expression and molecular markers related to muscle proteolysis (MURF1,

243 Fasting skeletal muscle molecular markers showed increased myostatin expression,

244 Benzene polycarboxylic acids (BPCA) are molecular markers specific for pyrogenic carbon (PyC) wh

245 tissue morphology and the expression of the molecular markers studied.

246 Molecular marker studies and pathologic analyses from su

247 These focal adhesions contain the expected molecular markers such as talin, vinculin, and p130Cas,

248 l response properties, and the expression of molecular markers such as zebrin II (ZII).

249 tes immunopositive for interneuron cell-type molecular markers, such as parvalbumin, calbindin, calre

250 Given a set of biallelic molecular markers, such as SNPs, with genotype values en

251 ces of fecal contamination in waterways, use molecular markers targeting host-associated bacteria in

252 Molecular marker testing may be helpful in guiding patie

253 The 2 most studied molecular marker testing techniques for indeterminate th

254 Molecular marker tests such as ThyroSeq version 2.1 are

255 ne H3-like protein Cse4/CENP-A acts as a key molecular marker that differentiates the special centrom

256 BR28, which binds to translocator protein, a molecular marker that is up-regulated by microglial acti

257 loss of Lhx2 led to upregulation of a set of molecular markers that are normally expressed in the tha

258 Identification of molecular markers that are related to different types of

259 ng plasma metabolites, we searched for novel molecular markers that arise before and after hyperglyce

260 logy that applies RenSeq to rapidly identify molecular markers that co-segregate with a pathogen resi

261 nding of sSC neurons is impeded by a lack of molecular markers that define specific cell types.

262 MALDI-MSI identified endogenous molecular markers that illustrated the villi structures

263 Molecular markers that predict failure of artemisinin co

264 llustrations, detailed text descriptions and molecular markers that selectively label muscle, nerves/

265 g Liver (PRL) family members have emerged as molecular markers that significantly correlate to the ab

266 on, we identified acini-like PCA and related molecular markers that significantly enhance prognostic

267 In addition, we identified molecular markers that were highly enriched in UCP1-posi

268 To identify standardized molecular markers that would allow prediction of prognos

269 his paper we propose myoglobin as a powerful molecular marker to evaluate the presence of non-declare

270 of peripheral blood samples might be a novel molecular marker to help early identification of patient

271 has been exploited in previous studies as a molecular marker to identify tiny cell populations in bo

272 These suggested eEF1A1 as a molecular marker to predict the selectivity and efficien

273 lticopy plasmepsin 2 constitutes a surrogate molecular marker to track piperaquine resistance.

274 Here we apply molecular markers to analyze its population structure an

275 s, some population assignment techniques use molecular markers to assign individuals to known groups.

276 s of artemisinin resistance and for defining molecular markers to assist in its elimination.

277 e-specific proteins provides a robust set of molecular markers to define the human PSC state and allo

278 Molecular markers to detect subtypes of cancer cells cou

279 lyses provide greater power than traditional molecular markers to detect the genetic consequences of

280 To provide powerful molecular markers to explore the population genetic dive

281 ubplate across development as well as unique molecular markers to extend the repertoire of subplate l

282 ity to accurately diagnose patients, develop molecular markers to measure disease burden, and choose

283 ck on tumors, with clinical implications for molecular markers to modify emerging treatments.

284 Use of efficacious molecular markers to obtain the required knowledge of th

285 ancer, there is lack of validated predictive molecular markers to optimize treatment choices for eith

286 ith a panel of layer- and cell-type-specific molecular markers to phenotype cortical microstructure.

287 d/or sst5TMD4 levels, might represent useful molecular markers to predict the ultimate response of pi

288 trawberry fruit and could be used to develop molecular markers to select phenolics-rich germplasm.

289 han previously appreciated in chickens using molecular markers to stain oral epithelial sheets of the

290 g pathobiology, studies linking pathology to molecular markers to targeted therapies are beginning to

291 To date, however, only few of the available molecular markers truly influence clinical decision-maki

292 erms of sampling distribution, the number of molecular markers used and the analytical techniques emp

293 he classification models allowed identifying molecular markers useful to distinguish TGT from other t

294 NAs-mRNAs networks and to identify potential molecular markers via a computational method.

295 ste buds in oral epithelial sheets using the molecular markers Vimentin and alpha-Gustducin.

296 The use of some of these chemicals as sewage molecular markers was also investigated.

297 Molecular markers were more sensitive than visible toxic

298 Our protocol for labeling taste buds with molecular markers will factilitate future mechanistic st

299 ng was also carried out using microsatellite molecular markers with high polymorphic and unambiguous

300 Molecular markers Xbarc113 and AFLP AGCTCG-347 on chromo